Research ArticleBasic Science Investigations
Development of 124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin
Ann-Marie Chacko, Chunsheng Li, Madhura Nayak, John L. Mikitsh, Jia Hu, Catherine Hou, Luigi Grasso, Nicholas C. Nicolaides, Vladimir R. Muzykantov, Chaitanya R. Divgi and George Coukos
Journal of Nuclear Medicine March 2014, 55 (3) 500-507; DOI: https://doi.org/10.2967/jnumed.113.121905
Ann-Marie Chacko
1Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
2Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Chunsheng Li
3Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and
Madhura Nayak
1Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
John L. Mikitsh
1Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Jia Hu
3Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and
Catherine Hou
1Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Luigi Grasso
4Morphotek, Inc., Exton, Pennsylvania
Nicholas C. Nicolaides
4Morphotek, Inc., Exton, Pennsylvania
Vladimir R. Muzykantov
2Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Chaitanya R. Divgi
1Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
George Coukos
3Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 3
March 1, 2014
Development of 124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin
Ann-Marie Chacko, Chunsheng Li, Madhura Nayak, John L. Mikitsh, Jia Hu, Catherine Hou, Luigi Grasso, Nicholas C. Nicolaides, Vladimir R. Muzykantov, Chaitanya R. Divgi, George Coukos
Journal of Nuclear Medicine Mar 2014, 55 (3) 500-507; DOI: 10.2967/jnumed.113.121905
Development of 124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin
Ann-Marie Chacko, Chunsheng Li, Madhura Nayak, John L. Mikitsh, Jia Hu, Catherine Hou, Luigi Grasso, Nicholas C. Nicolaides, Vladimir R. Muzykantov, Chaitanya R. Divgi, George Coukos
Journal of Nuclear Medicine Mar 2014, 55 (3) 500-507; DOI: 10.2967/jnumed.113.121905
Jump to section
Related Articles
Cited By...
- Endosialin-Expressing Pericytes Promote Metastatic Dissemination
- Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage
- T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression